{"id":"rxr","name":"Retinoid X receptor (RXR)","symbol":"RXRA, RXRB, RXRG","route":"/targets/rxr/","asOf":"2026-09-10","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:10477","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000186350","uniprot":"https://www.uniprot.org/uniprotkb/P19793/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P19793","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL2061","open-targets":"https://platform.opentargets.org/target/ENSG00000186350","civic":"https://civicdb.org/genes/6256/summary","oncokb":"https://www.oncokb.org/gene/RXRA","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=RXRA","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=RXRA","depmap":"https://depmap.org/portal/gene/RXRA?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000186350-RXRA","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/6256","omim":"https://www.omim.org/entry/180245"},{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:10478","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000204231","uniprot":"https://www.uniprot.org/uniprotkb/P28702/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P28702","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1870","open-targets":"https://platform.opentargets.org/target/ENSG00000204231","civic":"https://civicdb.org/genes/6257/summary","oncokb":"https://www.oncokb.org/gene/RXRB","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=RXRB","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=RXRB","depmap":"https://depmap.org/portal/gene/RXRB?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000204231-RXRB","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/6257","omim":"https://www.omim.org/entry/180246"},{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:10479","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143171","uniprot":"https://www.uniprot.org/uniprotkb/P48443/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P48443","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL2004","open-targets":"https://platform.opentargets.org/target/ENSG00000143171","civic":"https://civicdb.org/genes/6258/summary","oncokb":"https://www.oncokb.org/gene/RXRG","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=RXRG","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=RXRG","depmap":"https://depmap.org/portal/gene/RXRG?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000143171-RXRG","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/6258","omim":"https://www.omim.org/entry/180247"}],"products":[{"id":"acitretin","name":"Acitretin","status":"approved","modality":"Oral systemic retinoid","route":"/drugs/acitretin/"},{"id":"bexarotene","name":"Bexarotene","status":"approved","modality":"Small-molecule retinoid X receptor agonist","route":"/drugs/bexarotene/"},{"id":"isotretinoin","name":"Isotretinoin","status":"approved","modality":"Oral retinoid (differentiating agent)","route":"/drugs/isotretinoin/"}],"trials":[{"id":"acns0332","name":"COG ACNS0332","nct":"NCT00392327","phase":"3","status":"mixed"},{"id":"anbl0531","name":"ANBL0531","nct":"NCT00499616","phase":"3","status":"positive"},{"id":"alcanza","name":"ALCANZA","nct":"NCT01578499","phase":"3","status":"positive"},{"id":"anbl0032","name":"COG ANBL0032","nct":"NCT00026312","phase":"3","status":"positive"},{"id":"nct02050321","name":"A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma","nct":"NCT02050321","phase":"2"}],"pathways":["aml-signalling","sclc-signalling"],"companies":["bausch-health"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}